Aspira Women's Health Overview

  • Founded
  • 1993
Founded
  • Status
  • Public
  • Employees
  • 69
Employees
  • Stock Symbol
  • AWH
Stock Symbol
  • Investments
  • 4
  • Share Price
  • $5.11
  • (As of Friday Closing)

Aspira Women's Health General Information

Description

Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.

Contact Information

Formerly Known As
Vermillion, Inc., Ciphergen Biosystems, Vermillion
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Laboratory Services (Healthcare)
Stock Exchange
NAS
Primary Office
  • 12117 Bee Caves Road, Building III
  • Suite 100
  • Austin, TX 78738
  • United States
+1 (844) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aspira Women's Health Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.11 $4.85 $2.22 - $10.54 $572M 112M 660K -$0.71

Aspira Women's Health Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 742,577 682,165 65,467 12,383
Revenue 4,927 4,651 4,538 3,053
EBITDA (17,650) (14,963) (10,674)
Net Income (20,119) (17,905) (15,237) (11,371)
Total Assets 62,297 19,605 13,828 11,408
Total Debt 4,914 5,119 1,647 1,481
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aspira Women's Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aspira Women's Health‘s full profile, request access.

Request a free trial

Aspira Women's Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Aspira Women's Health‘s full profile, request access.

Request a free trial

Aspira Women's Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testin
Diagnostic Equipment
Austin, TX
69 As of 2020
00000
000000000 00000

00000000

o eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
0000000000 000000000
Irvine, CA
00 As of 0000
000.00
000000000 000.00

00000000

lit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
0000000000 000000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aspira Women's Health Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OncoCyte Pending Transaction (M&A) Irvine, CA 00 000.00 000000000 000.00
00000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
0000000 Formerly VC-backed San Francisco, CA 0000 00000 000000000 00000
00000000000 Venture Capital-Backed Birmingham, AL 00 00.000 0000000000 0 00.000
00000000 00000000 Venture Capital-Backed San Diego, CA 00 000.00 00000000
You’re viewing 5 of 13 competitors. Get the full list »

Aspira Women's Health Executive Team (14)

Name Title Board Seat Contact Info
Valerie Palmieri Chief Executive Officer & Board Member
Robert Beechey Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Kaile Zagger Chief Operating Officer, Operations
Lesley Northrop Ph.D Chief Scientific Officer
Diane Powis Executive
You’re viewing 5 of 14 executive team members. Get the full list »

Aspira Women's Health Board Members (9)

Name Representing Role Since
David Schreiber Aspira Women's Health Board Member 000 0000
James LaFrance Self Chairman & Board Member 000 0000
Valerie Palmieri Aspira Women's Health Chief Executive Officer & Board Member 000 0000
Veronica Jordan Ph.D Self Board Member 000 0000
You’re viewing 4 of 9 board members. Get the full list »

Aspira Women's Health Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aspira Women's Health Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aspira Women's Health‘s full profile, request access.

Request a free trial

Aspira Women's Health Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 (00000000000 05-Jan-2018 0000 00000 00.00 Educational Software
0000000000 0000000 19-Dec-2011 000000000000000000 00000 Diagnostic Equipment 0000 0000
0000000000 0000000 19-Dec-2011 000000000000000000 00000 Biotechnology 0000 0000
Perquest 27-Jul-2007 Later Stage VC 000.00 Consumer Finance
To view Aspira Women's Health’s complete investments and acquisitions history, request access »

Aspira Women's Health Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 27-Jul-2007 00000 00000 00 000.00 Completed
  • 3 buyers
To view Aspira Women's Health’s complete exits history, request access »